Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.96 USD | -0.55% | -1.15% | -0.87% |
May. 08 | Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.87% | 7.69B | |
+5.48% | 109B | |
+11.35% | 105B | |
-0.38% | 22.25B | |
-12.00% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.41% | 16.85B | |
+2.91% | 13.76B | |
+35.77% | 12.46B |
- Stock Market
- Equities
- CERE Stock
- News Cerevel Therapeutics Holdings, Inc.
- JPMorgan Raises Price Target on Cerevel Therapeutics Holdings to $45 From $25, Keeps Neutral Rating